Aldeyra Therapeutics Schedules Webcast and Conference Call for First Quarter 2015 Financial Results
May 11, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., May 11, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces Pricing of Follow-On Public Offering of Common Stock
May 08, 2015 08:00 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., May 8, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Launches Proposed Follow-on Public Offering of Common Stock
May 05, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Abstract Accepted for Presentation at the 2015 Multinational Association of Supportive Care in Cancer - International Society of Oral Oncology (MASCC-ISOO) Annual Meeting
April 23, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., April 23, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces First Patient Enrolled in Noninfectious Anterior Uveitis Phase II Clinical Trial
April 16, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., April 16, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Opens Enrollment in Noninfectious Anterior Uveitis Phase II Clinical Trial
March 26, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces First Patient Enrolled in Sjogren-Larsson Syndrome Phase II Clinical Trial
March 24, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 24, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Reports Full Year 2014 Financial Results
March 19, 2015 07:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 19, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Opens Enrollment in Sjogren-Larsson Syndrome Clinical Trial and Finalizes Noninfectious Anterior Uveitis Clinical Trial Protocol
March 17, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 17, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results
March 10, 2015 16:15 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., March 10, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...